This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorziglia, M. I.
Right arrow Articles by Kaleko, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorziglia, M. I.
Right arrow Articles by Kaleko, M.

 Previous Article  |  Next Article 

Journal of Virology, July 1999, p. 6048-6055, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Generation of an Adenovirus Vector Lacking E1, E2a, E3, and All of E4 except Open Reading Frame 3

Mario I. Gorziglia,* Claudia Lapcevich, Soumitra Roy, Qiang Kang, Mike Kadan, Vivian Wu, Peter Pechan, and Mike Kaleko

DNA Viral Vector Unit, Genetic Therapy, Inc., a Novartis Company, Gaithersburg, Maryland 20879

Received 23 November 1998/Accepted 9 April 1999

Toxicity and immunity associated with adenovirus backbone gene expression is an important hurdle to overcome for successful gene therapy. Recent efforts to improve adenovirus vectors for in vivo use have focused on the sequential deletion of essential early genes. Adenovirus vectors have been constructed with the E1 gene deleted and with this deletion in combination with an E2a, E2b, or E4 deletion. We report here a novel vector (Av4orf3nBg) lacking E1, E2a, and all of E4 except open reading frame 3 (ORF3) and expressing a beta -galactosidase reporter gene. This vector was generated by transfection of a plasmid carrying the full-length vector sequence into A30.S8 cells that express E1 and E2a but not E4. Production was subsequently performed in an E1-, E2a-, and E4-complementing cell line. We demonstrated with C57BL/6 mice that the Av4orf3nBg vector effected gene transfer with an efficiency comparable to that of the Av3nBg (wild-type E4) vector but that the former exhibited a higher level of beta -galactosidase expression. This observation suggests that E4 ORF3 alone is able to enhance RNA levels from the beta -galactosidase gene when the Rous sarcoma virus promoter is used to drive transgene expression in the mouse liver. In addition, we observed less liver toxicity in mice injected with the Av4orf3nBg vector than those injected with the Av3nBg vector at a comparable DNA copy number per cell. This study suggests that the additional deletion of E4 in an E1 and E2a deletion background may be beneficial in decreasing immunogenicity and improving safety and toxicity profiles, as well as increasing transgene capacity and expression for liver-directed gene therapy.

* Corresponding author. Mailing address: DNA Viral Vector Unit, Genetic Therapy, Inc., a Novartis Company, 938 Clopper Rd., Gaithersburg, MD 20879. Phone: (301) 258-4661. Fax: (301) 948-8034. E-mail: mario.gorziglia{at}pharma.novartis.com.

Journal of Virology, July 1999, p. 6048-6055, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Ganesh, S., Gonzalez Edick, M., Idamakanti, N., Abramova, M., VanRoey, M., Robinson, M., Yun, C.-O., Jooss, K. (2007). Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice. Cancer Res. 67: 4399-4407 [Abstract] [Full Text]  
  • Catalucci, D., Sporeno, E., Cirillo, A., Ciliberto, G., Nicosia, A., Colloca, S. (2005). An Adenovirus Type 5 (Ad5) Amplicon-Based Packaging Cell Line for Production of High-Capacity Helper-Independent {Delta}E1-E2-E3-E4 Ad5 Vectors. J. Virol. 79: 6400-6409 [Abstract] [Full Text]  
  • Stilwell, J. L., McCarty, D. M., Negishi, A., Superfine, R., Samulski, R. J. (2003). Development and Characterization of Novel Empty Adenovirus Capsids and Their Impact on Cellular Gene Expression. J. Virol. 77: 12881-12885 [Abstract] [Full Text]  
  • McVey, D., Zuber, M., Ettyreddy, D., Brough, D. E., Kovesdi, I. (2002). Rapid Construction of Adenoviral Vectors by Lambda Phage Genetics. J. Virol. 76: 3670-3677 [Abstract] [Full Text]  
  • Qiao, C., Li, J., Skold, A., Zhang, X., Xiao, X. (2002). Feasibility of Generating Adeno-Associated Virus Packaging Cell Lines Containing Inducible Adenovirus Helper Genes. J. Virol. 76: 1904-1913 [Abstract] [Full Text]  
  • Zhang, W., Low, J. A., Christensen, J. B., Imperiale, M. J. (2001). Role for the Adenovirus IVa2 Protein in Packaging of Viral DNA. J. Virol. 75: 10446-10454 [Abstract] [Full Text]  
  • Sen, L., Hong, Y.-S., Luo, H., Cui, G., Laks, H. (2001). Efficiency, efficacy, and adverse effects of adenovirus- vs. liposome-mediated gene therapy in cardiac allografts. Am. J. Physiol. Heart Circ. Physiol. 281: H1433-H1441 [Abstract] [Full Text]  
  • Hodges, B. L., Evans, H. K., Everett, R. S., Ding, E. Y., Serra, D., Amalfitano, A. (2001). Adenovirus Vectors with the 100K Gene Deleted and Their Potential for Multiple Gene Therapy Applications. J. Virol. 75: 5913-5920 [Abstract] [Full Text]  
  • Russell, W. C. (2000). Update on adenovirus and its vectors. J. Gen. Virol. 81: 2573-2604 [Full Text]  
  • O'Connor, R. J., Hearing, P. (2000). The E4-6/7 Protein Functionally Compensates for the Loss of E1A Expression in Adenovirus Infection. J. Virol. 74: 5819-5824 [Abstract] [Full Text]  
  • Sandig, V., Youil, R., Bett, A. J., Franlin, L. L., Oshima, M., Maione, D., Wang, F., Metzker, M. L., Savino, R., Caskey, C. T. (2000). Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. USA 97: 1002-1007 [Abstract] [Full Text]  
  • Miyamoto, M. I., del Monte, F., Schmidt, U., DiSalvo, T. S., Kang, Z. B., Matsui, T., Guerrero, J. L., Gwathmey, J. K., Rosenzweig, A., Hajjar, R. J. (2000). Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc. Natl. Acad. Sci. USA 97: 793-798 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»